Sonen Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.04M Buy
1,963
+162
+9% +$78.4K 1.98% 8
2023
Q3
$912K Buy
1,801
+66
+4% +$35.2K 1.79% 12
2023
Q2
$905K Buy
1,735
+142
+9% +$76.6K 1.5% 15
2023
Q1
$918K Buy
1,593
+260
+20% +$147K 1.56% 12
2022
Q4
$734K Buy
1,333
+25
+2% +$13.2K 1.2% 29
2022
Q3
$664K Sell
1,308
-360
-22% -$201K 1.08% 32
2022
Q2
$906K Sell
1,668
-377
-18% -$208K 1.3% 20
2022
Q1
$1.21M Sell
2,045
-742
-27% -$426K 1.46% 21
2021
Q4
$1.86M Buy
+2,787
New +$1.74M 1.8% 14

Other funds holding TMO

Sonen Capital's TMO Position: Q4 2023 in Review

Sonen Capital increased its Thermo Fisher Scientific (TMO) stake by 9% in Q4 2023, buying an estimated $78.4K and bringing the position to 1,963 shares worth $1.04M. The position accounts for 1.98% of the portfolio, ranked #8.

Sonen Capital first reported a position in TMO in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.86M in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Sonen Capital held 1,963 shares of Thermo Fisher Scientific worth $1.04M as of Q4 2023.
  • Sonen Capital bought 162 Thermo Fisher Scientific shares in Q4 2023, an estimated $78.4K.
  • Thermo Fisher Scientific made up 1.98% of Sonen Capital's portfolio in Q4 2023, its #8 holding.
  • Sonen Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 9 quarters since.
  • Sonen Capital's Thermo Fisher Scientific position peaked at $1.86M in Q4 2021.
  • 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Sonen Capital's 13F filing for Q4 2023, filed 2 Feb 2024.